NF2 mutations associated with SP-EPN usually occur either as germline or mosaic mutations in patients with NF2-related schwannomatosis (NF2), previously known as neurofibromatosis type 2 [38], or as somatic mutations in patients without NF2 [26, 39, 42, 47]. This evidence concerns the gene NF2 and NF2-related schwannomatosis.